Investment News

Guinness Ventures announces investment in Goodrays

We are pleased to announce our investment in Goodrays.

Founded by Eoin Keenan in 2020, Goodrays is redefining the functional drinks market with a mission to bring mental well-being to the forefront of the food and drinks industry.

Eoin’s personal journey, exploring solutions for anxiety and ultimately discovering the benefits of CBD, sparked the creation of a range of drinks designed to relieve stress, increase focus, and improve sleep.

Goodrays’ CBD-infused drinks contain 30mg of CBD and 0% THC, are vegan-friendly, low in calories, and enriched with vitamin D. Since its launch, the company has quickly become the one of the fastest-growing brands within the UK’s functional drinks category, achieving best-selling status in major retailers and consistently outperforming established beverage brands.

The company has built strong retail partnerships with Morrisons, Tesco, Sainsbury’s, Waitrose, and Ocado, and is poised to further expand through upcoming launches across additional national retailers and health stores. Internationally, Goodrays is gaining traction across key European markets, supported by regulatory tailwinds.

Guinness Ventures is excited to back Goodrays as it scales its presence and continues to lead innovation within this fast-evolving category. Our investment aligns with our strategy to support purpose-led, high-growth brands with strong leadership teams and global ambitions.

Congratulations to Eoin Keenan and the entire Goodrays team, we look forward to supporting you on the next stage of your journey.

Resources

View more

27 January 2026
News

Guinness Ventures announces investment in Evaro

Guinness Ventures announces investment in Evaro

Guinness Ventures is pleased to have participated as an investor in Evaro's $25m Series A funding round. 

Read more
18 December 2025
News

Guinness Ventures announces investment in GlycanAge

Guinness Ventures announces investment in GlycanAge

We are delighted to have participated in GlycanAge’s $8.7m (€7.4m) investment targeted funding round. GlycanAge is a biotechnology company transforming how individuals and healthcare providers understand healthy ageing through advanced glycan analysis.

Read more
21 September 2025
News

Guinness Ventures announces investment in YASO

Guinness Ventures announces investment in YASO

We are delighted to announce our investment in YASO, the operating system for global brands in China, following the close of its £8.26 million Series A funding round.

Read more